UFOK-ultraviolet radiation of blood

Each year, medical research and scientific advancements improve methods of rejuvenation and maintaining overall health. One such method is UVBI — ultraviolet blood irradiation, a procedure aimed at activating the body's self-recovery processes through low-intensity ultraviolet light. The procedure has shown excellent results with absolutely no side effects.

The History of UVBI

The first studies on the effects of ultraviolet radiation on the human body were conducted over 70 years ago. In 1928, American doctors performed an emergency operation to disinfect the blood of a woman dying from sepsis. They removed 100–120 ml of her blood, irradiated it with UV light, and reinfused it back into her body. As a result, the patient made a full recovery. Further research was carried out in the U.S. and Germany, significantly refining the method.

In the USSR, the first UV blood irradiation procedure was performed in 1937 under the supervision of Dr. Filatov. He believed that two factors played a key role in the treatment:

Bloodletting, which had been known for its healing effects since medieval times;
Reinfusion of blood previously exposed to ultraviolet light.

Prior to the invention of lasers — monochromatic light sources and LEDs — the procedure required blood to be drawn and treated externally. Thanks to technological progress, today’s process can be done intravenously. In 1979, a special device for performing UVBI was developed and tested, and it is still in use today.

There are several theories about what exactly happens to blood when exposed to ultraviolet light. According to one theory, UV exposure leads to the formation of sulfhydryl groups that activate dormant enzymes. Another theory suggests that peroxides appear in the blood, improving cellular metabolism and boosting the body's regenerative abilities.

Modern Methods of Performing the Procedure

Today, the UVBI procedure is performed intravenously using modern equipment. It employs reliable semiconductor lasers with a wavelength of 0.63 micrometers (633 nm). This wavelength can be adjusted thanks to the modular design of the device. The system has passed all necessary tests and is completely safe. It can even be used at home, as it does not require grounding like most bulky medical equipment.

During the procedure, fully sterile disposable needles and LED devices are attached to special laser heads directly on the unit. A peripheral vein is punctured with this needle, allowing for direct blood irradiation. Most commonly, wavelengths between 365–390 nm are used — corresponding to long-wave ultraviolet radiation — with a power output of 1.5–2 mW.

This procedure is recommended for conditions such as erysipelas, furunculosis, hepatitis, cholecystitis, varicose disease, pneumonia, peptic ulcer disease, ischemic heart disease (IHD), and hypertension.

Ultraviolet irradiation triggers a series of therapeutic effects in the body:

Improves oxygen delivery and movement within the bloodstream, providing antioxidant protection;
Reduces blood viscosity, preventing the formation of blood clots;
Removes various toxins from the body;
Enhances resistance to viral and bacterial infections;
Boosts metabolic activity, leading to general rejuvenation;
Destroys harmful microorganisms, thereby strengthening immunity.

The UVBI method is gradually being introduced into oncology treatments. For this purpose, patients are given a photosensitizer, which, when exposed to UV light, causes damage to rapidly dividing cells — including cancerous growths.

Contraindications for UVBI

Like any other medical procedure, UVBI may have contraindications based on the patient's clinical condition and individual characteristics. Before undergoing UVBI, it is strongly recommended to consult with a physician and undergo diagnosis to avoid unpleasant consequences.

UV irradiation is not recommended for people who are sensitive to this light spectrum or prone to photoallergic reactions. Using certain medications during the procedure — such as tetracyclines, phenothiazines, fluoroquinolones, and sulfonamides — may provoke allergic skin reactions.

If you suffer from any of the following conditions, it is better to either cancel the procedure or carry it out only under a doctor’s supervision:

Cardiovascular diseases in decompensation stage;
Stage II cerebral circulation disorders;
Pulmonary and cardio-pulmonary decompensation;
Malignant tumors;
Systemic nervous system diseases;
Feverish state;
Liver and kidney failure;
Hyperthyroidism;
Mental disorders;
Pregnancy.

Complications from ultraviolet irradiation are rare. Technical difficulties may arise during intravenous injection due to individual anatomical features. Very rarely, the procedure may cause chills, dizziness, or neurovegetative reactions.

UVBI at the "Berezoviy Gai" Health Resort

This procedure is prescribed by a doctor after a thorough examination and consultation. At this stage, all possible issues are identified, and optimal device parameters are selected, including:

Frequency;
Variability;
Wavelength;
Power level.

Thanks to precise parameter selection, UVBI targets problem areas in the body, enabling localized influence. To achieve visible results, a minimum of 4–10 sessions is usually required, depending on the severity of the illness. It should also be noted that the procedure works much more effectively when combined with etiopathogenetic treatment methods. At the "Berezoviy Gai" health resort, UVBI is prescribed by physicians and administered by highly qualified nurses.